Profile: Spherix Inc (SPEX.OQ)
22 Jul 2016
Spherix Incorporated (Spherix), incorporated on May 1, 1992, is an intellectual property company that owns patented and unpatented intellectual property. The Company is a patent commercialization company focused on generating revenues from the monetization of intellectual property. The Company owns over 290 patents and patent applications. The Company acquires intellectual property from patent holders in order to maximize the value of the patent holdings by conducting and managing a licensing campaign, or through the settlement and litigation of patents. Some patent holders tend to have limited internal resources and/or expertise to address the unauthorized use of their patented technologies or they simply make the strategic business decision to outsource their intellectual property licensing. They can include individual inventors, large corporations, universities, research laboratories and hospitals. Typically, the Company, or an operating subsidiary, acquires a patent portfolio in exchange for securities of the Company, an upfront cash payment, a percentage of its operating subsidiary's net recoveries from the licensing and enforcement of the portfolio, or a combination of the foregoing.
The Company's activities generally include the acquisition and development of patents through internal or external research and development. In addition, the Company seeks to acquire existing rights to intellectual property through the acquisition of already issued patents and pending patent applications, both in the United States and abroad. The Company may alone, or in conjunction with others, develop products and processes associated with its intellectual property and license its intellectual property to others seeking to develop products or processes or whose products or processes infringe its intellectual property rights through legal processes. Its intellectual property primarily consists of trade secrets, patented know-how, issued and pending patents, copyrights and technological innovation. The Company's patent portfolio includes both the United States and foreign patents and pending patent applications in the wireless communications and telecommunication sectors, including data, optical and voice technology, antenna technology, wireless fidelity (Wi-Fi), base station functionality, and cellular. The Company also owns patents related to artificial sweetener and prescription refill technology.
The Company competes with Vringo, Inc., VirnetX Holding Corp, Acacia Research Corporation, RPX Corporation and Marathon Patent Group, Inc.
1350 Avenue Of The Americas Fl 2
NEW YORK NY 10019